| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,595 |
9,212 |
$384K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,841 |
3,422 |
$223K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
4,992 |
4,660 |
$92K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,744 |
2,656 |
$50K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
942 |
936 |
$48K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
803 |
779 |
$40K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
736 |
731 |
$38K |
| 90461 |
|
1,631 |
1,591 |
$26K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,532 |
2,142 |
$24K |
| 92587 |
|
860 |
860 |
$21K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
328 |
322 |
$19K |
| 92558 |
|
2,370 |
2,233 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
762 |
472 |
$7K |
| 90686 |
|
623 |
600 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
71 |
66 |
$3K |
| 96127 |
|
667 |
652 |
$1K |
| 99173 |
|
949 |
867 |
$1K |
| 90656 |
|
95 |
95 |
$493.58 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
14 |
14 |
$455.50 |
| 90685 |
|
13 |
13 |
$254.87 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
12 |
12 |
$87.61 |
| 99000 |
|
879 |
793 |
$7.50 |
| 99072 |
|
216 |
198 |
$0.00 |